Chimeric antigen receptor (CAR)-T cell therapy has generated unprecedented advances in the treatment of hematologic cancers, but readily translatable imaging approaches to visualize the in vivo dynamics of CAR-T cells are lacking. Noninvasive PET imaging is the ideal tool to monitor CAR-T cells.
CITATION STYLE
Volpe, A., Nagle, V. L., Lewis, J. S., & Ponomarev, V. (2021). Predicting CAR-T cell Immunotherapy Success through ImmunoPET. Clinical Cancer Research, 27(4), 911–912. https://doi.org/10.1158/1078-0432.CCR-20-4297
Mendeley helps you to discover research relevant for your work.